Studies show that adding a GLP-1 to insulin therapy can reduce insulin requirements by 20-50%, meaning your current dose may cause dangerously low blood sugar without adjustment
Three major barriers must be overcome to ensure that everyone globally whose health would benefit from GLP-1s can get them: lack of production capacity, availability and affordability
Its core physiological function is to catalyze the methylation of nicotinamide (NAM, a key precursor for NAD+ synthesis) with Sadenosylmethionine (SAM) to produce 1methylnicotinamide (1MNA)
Acarbose Longevity Protocol Extensively researched for longevity, acarbose supports healthspan by flattening sugar spikes, boosting GLP-1, and strengthening gut health
Corsini, EM, Mitchell, KG, Correa, AM, Morris, VK, Antonoff, MB, Zhou, N, Hofstetter, WL, Mehran, RJ, Rice, DC, Roth, JA, Sepesi, B, Swisher, SG , Vaporciyan, AA, Walsh, GL
Abstract Obesity is a risk factor for developing and worsening multiple sclerosis (MS) and is often comorbid with MS, exacerbating disability